Masaru Matsuda - 31 May 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Reporting Person's title: Senior Vice President General Counsel and Corporate Secretary
Signature: /s/ David Topper, as Attorney-in-Fact for Masaru Matsuda
Issuer symbol: ARQT
Transactions as of: 31 May 2024
Net transactions value: +$18,543
Form type: 4
Filing time: 03 Dec 2024, 16:16:58 UTC
Previous filing: 29 May 2024
Next filing: 05 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Purchase	$6,768	+4,000	+2.2%	$1.69	185,373	31 May 2024	Direct	F1
transaction	ARQT	Common Stock	Purchase	$11,775	+1,657	+0.89%	$7.11	187,030	30 Nov 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the purchase transaction of the Company's Employee Stock Purchase Plan.

Remarks:

Reporting Person's title: Senior Vice President General Counsel and Corporate Secretary